Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Exparel® (bupivacaine) – Expanded indication
March 22, 2021 - Pacira BioSciences announced the FDA approval of Exparel (bupivacaine), in patients aged 6 years and older for single-dose infiltration to produce postsurgical local analgesia.
